Emergent BioSolutions among 2010 tech awards finalists

ROCKVILLE, Md. Read More »

Flu shot safe for most egg allergic children, study says

NEW YORK Read More »

Millions of H1N1 vaccine doses may have to be discarded

Despite months of dire warnings and millions in taxpayer dollars, less than half of the 229 million doses of H1N1 vaccine the government bought to fight the pandemic have been administered. Read More »

Selecta raises $15 million to advance potential vaccine

A Massachusetts startup that uses nanotechnology to engineer safer and more effective vaccines is expected to say April 5 that it has raised another $15 million in venture capital to finance the further development of its products according to the Boston Read More »

CDC reports states' H1N1 flu inoculation rates vary widely

The Centers for Disease Control and Prevention reported that the vaccination rates for the pandemic H1N1 influenza virus are different around the country. New England has the highest rates while the South is having the lowest. Read More »

U.S. has record drop in TB rates

Tuberculosis rates in the United States dropped more than 10 percent last year compared with 2008, the sharpest decrease ever recorded in a single year, the Centers for Disease Control and Prevention reported March 31. Read More »

GlaxoSmithKline launches free vaccine program

NEW YORK Read More »

Basketball superstars urge teens to stay in the game

DETROIT Read More »

Peregrine says study shows anti-HIV potential of antibodies

Peregrine Pharmaceuticals Inc. announced April 5 the publication of data showing phosphatidylserine (PS)-targeting antibodies can block one of the key ways the AIDS virus gains entry into certain blood cells. Read More »

Measles alert issued after dozen cases diagnosed

The British Columbia Centre for Disease Control is warning health care professionals and the public to be on the alert for measles after nearly a dozen people in Vancouver were diagnosed recently with the disease, Canwest News Service reported. Read More »

Canada cuts off funding to international AIDS vaccine project

OTTAWA Read More »

Small molecules have big impact for TB bacteria

Mycobacterium tuberculosis (Mtb) possesses extraordinary survival ability by masking itself from the host immune system and persisting for decades inside the host. Read More »

Resurgence of mumps seen in males in Ireland

Urologists at a leading Irish hospital have reported an alarming increase in the number of teenage boys and young men developing mumps orchitis, in a paper published in the April issue of the urology journal BJUI. Read More »

CDC updates advice for travelers

The Centers for Disease Control and Prevention reports that the 2009 H1N1 flu viruses are expected to circulate throughout 2010, including during the Southern Hemisphere flu season. Read More »

UK vaccine makes strides in melanoma treatment

LONDON Read More »

Sanofi-Aventis, Navy to test traveler's diarrhea vaccine

NEW YORK Read More »

"Nanovaccine" reverses diabetes in mice, researchers say

A new study, published online April 8 by Cell Press in the journal Immunity, describes a therapeutic "nanovaccine" that successfully reverses diabetes in a mouse model of the disease. Read More »

Inovio, universities receive grant to develop hepatitis C vaccine


NIH gives $3M grant for malaria vaccine

Support from the National Institute of Allergy and Infectious Disease of the NIH has given Protein Potential, LLC support in its research for a vaccine to prevent malaria caused by the Plasmodium vivax parasite. Read More »

WHO warns H1N1 to continue through 2011

The head of the World Health Organization has warned that the H1N1 flu pandemic might not be conquered until 2011 and that continued vigilant is necessary against the mutating virus. Read More »